Silicon Genetics Acquired by Agilent
In the most recent fiscal year, Agilent derived 42 percent of its revenue from test and measurement tools, 13 percent from automated testing tools, 26 percent from semiconductor products, and 20 percent from chemical analysis. For that year, revenue was virtually stagnant at $6.1 billion.
Financial terms of the Silicon Genetics deal remain disclosed.
Read the full story at Bio-IT World